Chair Samuel Achilefu, Ph.D., is featured in this Science in 60+. Learn about his invention, Medical Vision Goggles, which help surgeons eliminate all cancer cells after tumor removal. The goal is to make them available to surgeons worldwide. bit.ly/3F6qAFg #UTSWScience

Science at #UTSW goes deep – down to the nucleic level. Research led by Daniel Siegwart has unlocked synthetic lipid nanoparticles as delivery vehicles for genetic medicines. Explore more in the latest edition of #DiscoveryAtUTSW. bit.ly/43AO6Ej

👏 Huge congratulations to Ys from the GDEatUTSW Lab for winning a travel award at the 2025 Celebration of Women in Science and Medicine! Her innovative work on in vivo editing of lung stem cells is truly inspiring. 🚀🔬 #WomenInSTEM #GeneEditing #UTSWBME

Welcome our new postdocs, Dr. Koki Kunitake and Dr. Xi Liu! 🎉 Excited to have you both on board! 🔬✨ #Welcome #Postdocs #Research

Minigolf Monday Recap! We had a really great time at minigolf with the whole lab crew this Monday! ⛳️🙌 #LabLife

Advancing Multi-Organ Gene Editing We’re excited to announce that Dr. Minjeong Kim and the team have developed a revolutionary gene-editing system capable of targeting livers and lungs simultaneously. Check out our feature in @UTSWNews: utsouthwestern.edu/newsroom/artic…

🎉 Big News! 🎉 Huge congratulations to Amogh Vaidya, Graduate Student Researcher in the GDEatUTSW, who successfully defended his dissertation: "Development of Organ-specific Lipid Nanoparticles for Delivery of Nucleic Acid Therapeutics" Congrats, Dr. Vaidya! 🧑‍🎓🔬 #PhDLife

It was an honor to be inducted into the National Academy of Inventors (NAI) ⁦⁦National Academy of Inventors⁩ tonight!

Daniel J. Siegwart on Development of selective organ targeting (SORT) lipid nanoparticles (LNPs) for genome correction of disease causing mutations #RNATx2025

Imagine treating a genetic disease affecting the lungs and liver with a single treatment. UTSW scientists are working to make this a reality. Discover how their innovative gene-editing delivery system could one day transform treatment options. bit.ly/3G4oWEy #GeneTherapy

Our new 3-component ZAL LNPs simplify mRNA delivery and enable extra-hepatic delivery. Acetate-modified ZALs show enhanced biocompatibility and immune cell transfection—paving the way for next-gen mRNA therapies! 🧬✨ #LNP #mRNA #DrugDelivery Read more: pubs.acs.org/doi/10.1021/ac…

Rescued by fat bubbles: UTSW scientists treat rare genetic disease with designer molecule dallasnews.com/news/2025/07/1…

Congratulations to Raiyan Zaman, Ph.D., Lukas Farbiak, Ph.D., and Jing Liu, Ph.D., who were recognized at today's department meeting for their years of service! Thank you for your dedication and hard work to the UT System. 🥳 🎉

🚀 New publication from our lab! We found that pKa (6.2–7.4) and buffering capacity may be valuable in predicting in vivo hepatic delivery. #RNAtherapy #LNP Read more: pubs.acs.org/doi/10.1021/ac…

Big congratulations to Yehui Sun, a PhD candidate in Siegwart Lab, for receiving the 2025 Ida M. Green Award! Your dedication, leadership, and excellence truly inspire us all!

🚨 Exciting news! Dan is giving a talk on the development of selective organ targeting (SORT) lipid nanoparticles (LNPs) for genome correction of disease-causing mutations. Daniel Siegwart Controlled Release Society #CRS2025 #Nanomedicine #LNP #GenomeEditing

Yehui Sun, PhD candidate in GDEatUTSW Lab, was presented with the Ida M. Green Award on Friday, July 11 during a small reception. Congratulations to Yehui for her commitment to research excellence, the well-being of fellow students and community service!

Our lab member Yufen Yufen Xiao gave a fantastic talk on her recent publication: "High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated mRNA therapeutic delivery." at the #CRS2025! Congrats! 🎉 #mRNA #LNP